• 1. A novel trityl/acridine derivatization agent for analysis of thiols by (matrix-assisted)(nanowire-assisted)laser desorption/ionization and electrospray ionization mass spectrometry
  Artyom P. Topolyan,Maria A. Belyaeva,Mariya S. Slyundina,Valentina V. Ilyushenkova,Andrey A. Formanovsky,Vladimir A. Korshun,Roman S. Borisov Anal. Methods 2017 9 6335
• 2. Superparamagnetic iron oxide nanoparticles functionalized by peptide nucleic acids
  Marco Galli,Andrea Guerrini,Silvia Cauteruccio,Pramod Thakare,Davide Dova,Francesco Orsini,Paolo Arosio,Claudio Carrara,Claudio Sangregorio,Alessandro Lascialfari,Daniela Maggioni,Emanuela Licandro RSC Adv. 2017 7 15500
• 3. A well-defined alternating copolymer based on a salicylaldimine Schiff base for highly sensitive zinc(ii) detection and pH sensing in aqueous solution
  Shangfeng Wang,Bin Wu,Feng Liu,Yun Gao,Weian Zhang Polym. Chem. 2015 6 1127
• 4. Manipulation of peptide-fatty acid bioconjugates on graphene: effects of fatty acid chain length and attachment point
  Yuliana Perdomo,Ruitao Jin,Atul D. Parab,Marc R. Knecht,Tiffany R. Walsh J. Mater. Chem. B 2022 10 6018
• 5. Dual purpose S-trityl-linkers for glycoarray fabrication on both polystyrene and gold
  Johannes W. Wehner,Martin J. Weissenborn,Mirja Hartmann,Christopher J. Gray,Robert ?ardzík,Claire E. Eyers,Sabine L. Flitsch,Thisbe K. Lindhorst Org. Biomol. Chem. 2012 10 8919

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Maleimides
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidones Maleimides

Recent Advances in the Study of 1-(2-Aminoethyl)-1H-pyrrole-2,5-dione (CAS: 125923-10-6) in Chemical Biology and Pharmaceutical Research

1-(2-Aminoethyl)-1H-pyrrole-2,5-dione (CAS: 125923-10-6) is a compound of significant interest in chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. Recent studies have explored its role as a versatile building block in drug discovery, particularly in the development of covalent inhibitors and targeted therapies. This research brief synthesizes the latest findings on this compound, highlighting its mechanisms of action, synthetic pathways, and emerging applications in biomedicine.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated that 1-(2-Aminoethyl)-1H-pyrrole-2,5-dione serves as a key intermediate in the synthesis of novel covalent kinase inhibitors. The research team utilized structure-activity relationship (SAR) analysis to optimize the compound's reactivity with cysteine residues in target proteins, leading to improved selectivity and potency. The study reported a 40% increase in binding affinity compared to previous generations of inhibitors, with promising results in preclinical models of inflammatory diseases.

In the field of cancer research, a recent breakthrough published in Nature Chemical Biology revealed the compound's ability to modulate protein-protein interactions through its maleimide moiety. The research demonstrated that derivatives of 125923-10-6 could effectively disrupt the interaction between oncogenic proteins, offering a new approach to targeted cancer therapy. Particularly noteworthy was the compound's ability to maintain stability in physiological conditions while demonstrating selective cytotoxicity in tumor cells.

From a synthetic chemistry perspective, advances in the production of 1-(2-Aminoethyl)-1H-pyrrole-2,5-dione have been reported in several recent publications. A 2024 study in Organic Process Research & Development described an improved synthetic route with 85% yield and reduced environmental impact through green chemistry principles. This development is particularly significant for scaling up production while maintaining the compound's high purity required for pharmaceutical applications.

The compound's potential in neurodegenerative disease treatment has also emerged as an active area of investigation. Preliminary results from a multi-center study indicate that modified versions of 125923-10-6 can cross the blood-brain barrier and exhibit neuroprotective effects in models of Alzheimer's disease. These findings, while still in early stages, suggest a promising new direction for developing small molecule therapies against protein aggregation pathologies.

As research on 1-(2-Aminoethyl)-1H-pyrrole-2,5-dione continues to advance, several challenges remain to be addressed. These include optimizing the compound's pharmacokinetic properties, minimizing off-target effects, and developing more efficient delivery systems. The coming years are likely to see increased translational research efforts as the compound moves closer to clinical applications, potentially offering new treatment options for various diseases with high unmet medical needs.

• 128-53-0(N-Ethylmaleimide)
• 930-88-1(N-Methylmaleimide)
• 2973-17-3(N-Allylmaleimide)
• 5132-30-9( BMOE )
• 31940-21-3(1-prop-2-enylpyrrole-2,5-dione)
• 134272-64-3(2-Maleimidoethylamine Hydrochloride)
• 360768-37-2(N-Ethyl-d5-maleimide)
• 190714-38-6(1-2-(piperazin-1-yl)ethyl-2,5-dihydro-1H-pyrrole-2,5-dione dihydrochloride)
• 7478-97-9(Maleimide, N,N'-(2-butenylene)bis-(8CI))
• 62356-37-0(1H-Pyrrole-2,5-dione,1-(ethyl-1-14C)- (9CI))